Literature DB >> 11682251

Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.

O V Rice1, S J Gatley, J Shen, C L Huemmer, R Rogoz, O T DeJesus, N D Volkow, A N Gifford.   

Abstract

Several studies have indicated that the in vivo binding of D(2) receptor positron emission tomography radiotracers can, under some conditions, be influenced by competition with endogenous dopamine. The present study was undertaken to compare the extent to which the in vivo binding in mice of radiotracers to other amine neuroreceptors, namely D(1), 5-HT(2A) and 5-HT(1A) receptors, can also be modulated by neurotransmitter competition. For dopamine radiotracers we examined [3H]raclopride as a D(2) radiotracer and [3H]A69024 as a D(1) radiotracer. Striatal binding of both radiotracers was substantially reduced by administration of the dopamine releaser, amphetamine, although only at a high dose. [3H]raclopride was decreased more than [3H]A69024. Dopamine depletion with 4-hydroxybutyrate strongly increased [3H]raclopride binding but failed to increase [3H]A69024 binding. For 5-HT radiotracers we examined [3H]N-methylspiperone as a 5-HT(2A) radiotracer and [3H]WAY 100635 as a 5-HT(1A) radiotracer. Cortical binding of both radiotracers was unaffected by the 5-HT releaser, p-chloroamphetamine. [3H]WAY 100635 binding was additionally unaffected by 5-HT release with fenfluramine and by 5-HT depletion with p-chlorophenylalanine. In conclusion, of the four radiotracers examined, [3H]raclopride binding to D(2) receptors had greatest sensitivity to changes in endogenous neurotransmitter levels. [3H]A69024 binding to D(1) receptors was affected only by neurotransmitter increases. [3H]N-methylspiperone binding to 5-HT(2A) receptors and [3H]WAY 100635 binding to 5-HT(1A) receptors appeared insensitive to changes in neurotransmitter levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682251     DOI: 10.1016/S0893-133X(01)00287-1

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  6 in total

1.  Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Elizabeth O Ahlers; Maxim Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-04       Impact factor: 6.200

2.  Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway.

Authors:  Dustin W Wooten; Ansel T Hillmer; Dhanabalan Murali; Todd E Barnhart; Joanne P Thio; Alisha K Bajwa; Ali A Bonab; Marc D Normandin; Mary L Schneider; Jogeshwar Mukherjee; Bradley T Christian
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

Review 3.  PET Neurochemical Imaging Modes.

Authors:  Michael S Placzek; Wenjun Zhao; Hsiao-Ying Wey; Thomas M Morin; Jacob M Hooker
Journal:  Semin Nucl Med       Date:  2016-01       Impact factor: 4.446

Review 4.  Decoding Neurotransmitter Switching: The Road Forward.

Authors:  Hui-Quan Li; Marta Pratelli; Swetha Godavarthi; Stefania Zambetti; Nicholas C Spitzer
Journal:  J Neurosci       Date:  2020-05-20       Impact factor: 6.167

Review 5.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

6.  PET imaging reveals brain functional changes in internet gaming disorder.

Authors:  Mei Tian; Qiaozhen Chen; Ying Zhang; Fenglei Du; Haifeng Hou; Fangfang Chao; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-16       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.